CRISPRclean Advantage Explore cross-sell opportunities with customers seeking higher sensitivity in NGS workflows by leveraging Jumpcode Genomics CRISPRclean technology to remove uninformative sequences, boosting pathogen detection and oncology research capabilities.

Clinical & Infectious Position Jumpcode as enabling improved clinical diagnostics and infectious disease surveillance through partnerships with institutions and CROs, highlighting the expanded RNA depletion portfolio and Single Cell RNA Boost Kit for enhanced sample access and data yield.

Strategic Partnerships Leverage existing collaborations (BARDA, Element Biosciences, TGen) to approach similar biopharma, public health, and sequencing platform partners for co-marketing, joint validation, and integrated solution bundles.

Platform Synergy Target customers using compatible sequencing ecosystems (AVITI, NGS platforms, cloud-based analytics) with integrated Jumpcode workflows to drive adoption of CRISPRclean solutions across diverse sample types and library preparations.

Growth Readiness Highlight scalable, modular depletion kits and cloud-enabled data processing as value drivers for growing biotech startups and mid-sized genomics labs seeking faster, more cost-efficient discovery pipelines.